These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21055615)

  • 1. Comparison of the stability of Y-90-, Lu-177- and Ga-68- labeled human serum albumin microspheres (DOTA-HSAM).
    Wunderlich G; Schiller E; Bergmann R; Pietzsch HJ
    Nucl Med Biol; 2010 Nov; 37(8):861-7. PubMed ID: 21055615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The radiometal makes a difference. Synthesis and preliminary characterisation of DOTA-minigastrin analogue complexes with Ga, Lu and Y.
    Maurin M; Garnuszek P; Baran P; Pawlak D; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2015; 18(2):51-5. PubMed ID: 26315862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
    Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC
    Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability.
    Schiller E; Bergmann R; Pietzsch J; Noll B; Sterger A; Johannsen B; Wunderlich G; Pietzsch HJ
    Nucl Med Biol; 2008 Feb; 35(2):227-32. PubMed ID: 18312833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities.
    Breeman WA; De Jong M; Visser TJ; Erion JL; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):917-20. PubMed ID: 12677301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
    Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R
    J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAZTA
    Klasen B; Moon ES; Rösch F
    Nucl Med Biol; 2021; 96-97():80-93. PubMed ID: 33839678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases.
    Ogawa K; Kawashima H; Shiba K; Washiyama K; Yoshimoto M; Kiyono Y; Ueda M; Mori H; Saji H
    Nucl Med Biol; 2009 Feb; 36(2):129-35. PubMed ID: 19217524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro evaluation of
    Zhang J; Wang Z; Liu H; Cai L; Feng Y; Zhou L; Wei H; Xie Y; Chen Y
    Hell J Nucl Med; 2019; 22(2):103-110. PubMed ID: 31273351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.
    Ujula T; Huttunen M; Luoto P; Peräkylä H; Simpura I; Wilson I; Bergman M; Roivainen A
    Bioconjug Chem; 2010 Sep; 21(9):1612-21. PubMed ID: 20795647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
    Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
    Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the
    Läppchen T; Bilinska A; Pilatis E; Menéndez E; Imlimthan S; Moon ES; Afshar-Oromieh A; Rösch F; Rominger A; Gourni E
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
    Stein R; Govindan SV; Chen S; Reed L; Richel H; Griffiths GL; Hansen HJ; Goldenberg DM
    J Nucl Med; 2001 Jun; 42(6):967-74. PubMed ID: 11390564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [
    Günther T; Holzleitner N; Viering O; Beck R; Wienand G; Dierks A; Pfob CH; Bundschuh RA; Kircher M; Lapa C; Wester HJ
    J Nucl Med; 2024 Jan; 65(1):33-39. PubMed ID: 37945383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.
    Huclier-Markai S; Kerdjoudj R; Alliot C; Bonraisin AC; Michel N; Haddad F; Barbet J
    Nucl Med Biol; 2014 May; 41 Suppl():e36-43. PubMed ID: 24361353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and Biodistribution of Thiol-Functionalized and (177)Lu-Labeled Metal Chelating Polymers Bound to Gold Nanoparticles.
    Yook S; Lu Y; Jeong JJ; Cai Z; Tong L; Alwarda R; Pignol JP; Winnik MA; Reilly RM
    Biomacromolecules; 2016 Apr; 17(4):1292-302. PubMed ID: 26974228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo comparison of DOTA based 68Ga-labelled bisphosphonates for bone imaging in non-tumour models.
    Meckel M; Fellner M; Thieme N; Bergmann R; Kubicek V; Rösch F
    Nucl Med Biol; 2013 Aug; 40(6):823-30. PubMed ID: 23915801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats.
    Ni HC; Yu CY; Chen SJ; Chen LC; Lin CH; Lee WC; Chuang CH; Ho CL; Chang CH; Lee TW
    Appl Radiat Isot; 2015 May; 99():117-21. PubMed ID: 25748057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.
    Kang CS; Chen Y; Lee H; Liu D; Sun X; Kweon J; Lewis MR; Chong HS
    Nucl Med Biol; 2015 Mar; 42(3):242-9. PubMed ID: 25487552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.